Joseph Black, M.S., is an Associate Director with the pricing and market access team of MKTXS, and has been with the company since March 2012. In his time at MKTXS, Joe has worked on a variety of projects in US, EU, and emerging markets across multiple therapeutic areas. He has overseen engagements involving quantitative pricing studies, qualitative primary and secondary research, value message testing, international reference pricing mitigation measures, managed entry agreements, healthcare policy and reimbursement systems, and global pricing strategy.
Vidya Ramesh, M.S., is an Associate Director responsible for the planning, management and delivery of Pricing and Market Access / Reimbursement projects across the US, EU and global markets. Vidya has successfully managed numerous projects related to the development, commercialization and lifecycle management of technologies in different stages of development, spanning across various therapeutic areas. She has been with Market Access Solutions since 2012.
Anshul Shah, Pharm D, MS (Pharmacy Administration) is a Senior Analyst with the HEOR team of MKTXS. As a Senior Analyst, Anshul has worked on various HEOR projects across multiple disease areas including oncology, immunology, Cardiopulmonology. His current project work includes primarily performing systematic reviews, developing customizable and interactive economic models (BIM, CEA, CUA, disease model), and retrospective database analysis to identify trends and utilization of healthcare resources. Anshul has also formulated several manuscripts and poster from these engagements. In the past, Anshul has also played supporting role in various qualitative primary and secondary research engagements as well as price-simulation models.
Anshul is proficient with Excel-VBA and has an advance level certification of SAS 9. He has worked on various secondary databases such as Truven MarketScan, H-CUP, MEPS, NHANES. He is also knowledgeable in healthcare systems and HTA processes across major EU markets.
Anshul holds a Bachelors in Pharmacy (Pharm. D. equivalent) from Gujarat University in India, and Masters in Pharmacy Administration from St. John’s University, NY.
Abner Nyandege, MS (Med. Chem.), PhD (Pharmacoepidemiology) is an analyst with experience in study designing, major data manipulation, and analysis of large claims and survey data using SAS. Before joining MKTXS, he completed his PhD in Pharmacoeconomics and Health Outcomes with a focus in pharmacoepidemiology. After joining MKTXS, he has gained experience in conducting studies to assess treatment patterns, healthcare resource utilization and costs, comparative-effectiveness, and treatment comparisons. His analytical skills include application of advanced statistical methods such as propensity score matching, descriptive and multivariable analyses, survival analysis, and application of generalized linear model approaches. Other skills include interpreting and summarizing analyses results for abstracts, posters, and publication.
Abner holds a Bachelor of Science degree from Moi University in Kenya; Masters in medicinal chemistry and PhD in pharmacoepidemiology from Virginia Commonwealth University.